Virtu Financial LLC Takes $631,000 Position in Humana Inc. (NYSE:HUM)

Virtu Financial LLC acquired a new stake in shares of Humana Inc. (NYSE:HUM - Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor acquired 1,993 shares of the insurance provider's stock, valued at approximately $631,000.

Several other large investors have also recently made changes to their positions in the business. Creative Financial Designs Inc. ADV lifted its position in Humana by 244.0% in the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider's stock valued at $27,000 after purchasing an additional 61 shares during the last quarter. CarsonAllaria Wealth Management Ltd. boosted its position in Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider's stock valued at $28,000 after buying an additional 39 shares during the period. Atwood & Palmer Inc. bought a new stake in Humana in the 3rd quarter worth $29,000. Ashton Thomas Securities LLC purchased a new position in shares of Humana in the third quarter valued at about $31,000. Finally, Your Advocates Ltd. LLP boosted its holdings in shares of Humana by 81.8% during the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider's stock worth $32,000 after purchasing an additional 45 shares during the period. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Stock Performance

HUM traded up $1.34 during midday trading on Friday, hitting $274.12. 1,383,466 shares of the company traded hands, compared to its average volume of 1,841,710. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $486.00. The firm has a market capitalization of $33.01 billion, a PE ratio of 24.28, a price-to-earnings-growth ratio of 2.15 and a beta of 0.53. The company's 50-day moving average is $274.13 and its 200 day moving average is $324.53.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping the consensus estimate of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The company had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. On average, research analysts expect that Humana Inc. will post 16.14 EPS for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.29%. The ex-dividend date is Tuesday, December 31st. Humana's dividend payout ratio is presently 31.36%.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on HUM shares. Stephens reiterated an "equal weight" rating and issued a $250.00 price objective on shares of Humana in a report on Wednesday, October 9th. Truist Financial reduced their price objective on shares of Humana from $400.00 to $260.00 and set a "hold" rating on the stock in a research report on Friday, October 11th. JPMorgan Chase & Co. lifted their target price on shares of Humana from $332.00 to $396.00 and gave the company a "neutral" rating in a research note on Wednesday, August 21st. Barclays boosted their price target on shares of Humana from $250.00 to $253.00 and gave the company an "equal weight" rating in a research report on Thursday, October 31st. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on Humana from $349.00 to $250.00 and set a "hold" rating on the stock in a research report on Thursday, October 3rd. Twenty investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $304.15.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.